Logo image of VTVT

VTV THERAPEUTICS INC- CL A (VTVT) Stock Analyst Earnings Estimates

NASDAQ:VTVT - Nasdaq - US9183852048 - Common Stock - Currency: USD

15.3  +1.27 (+9.05%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
VTVT revenue by date.VTVT revenue by date.
2.02M
-49.63%

-100.00%
1.017M
-100.00%
11.832M44.166M
273.28%
85.884M
94.46%
EBITDA
YoY % growth
VTVT ebitda by date.VTVT ebitda by date.
-22.45M
-12.42%
-25.412M
-13.19%
-24.091M
5.20%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
VTVT ebit by date.VTVT ebit by date.
-22.54M
-12.36%
-25.502M
-13.14%
-24.18M
5.18%
-30.513M
-26.19%
-41.591M
-36.30%
-50.286M
-20.91%
-60.792M
-20.89%
-47.328M
22.15%
-41.412M
12.50%
Operating Margin
VTVT operating margin by date.VTVT operating margin by date.
-1,115.84%N/A-2,377.58%N/AN/AN/A-513.79%-107.16%-48.22%
EPS
YoY % growth
VTVT eps by date.VTVT eps by date.
-4.54
-1,963.64%
N/A
91.69%
N/A
-886.49%
-3.64
2.19%
-3.71
-1.96%
-3.87
-4.26%
-3.36
13.31%
-2.54
24.32%
-2.08
18.07%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.92
-900.00%
-1.04
-89.16%
Revenue
Q2Q % growth

-100.00%
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-8.16M
-25.42%
-9.053M
-85.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.92
-1,027.45%
-0.84-0.08-9.33%
Q1 2025
Q2Q % growth
-0.77
34.19%
-0.830.067.37%
Q4 2024
Q2Q % growth
-0.55
-413.54%
-0.890.3438.02%
Q3 2024
Q2Q % growth

-14.75%
-0.09%
Q2 2024
Q2Q % growth
-0.08%
Q1 2024
Q2Q % growth
-1.17
51.25%
-0.08-1.09-1,333.82%
Q4 2023
Q2Q % growth

95.54%
-0.11%
Q3 2023
Q2Q % growth
-0.08
96.00%
-0.110.0325.30%
Q2 2023
Q2Q % growth

-104.00%
-0.08%
Q1 2023
Q2Q % growth
-2.40
-2,300.00%
-3.881.4838.08%
Q4 2022
Q2Q % growth
-2.40
-2,081.82%
-2.580.187.12%
Q3 2022
Q2Q % growth
-2.00
-9,900.00%
-1.77-0.23-13.13%
Q2 2022
Q2Q % growth
-0.04
-300.00%
-0.090.0556.43%
Q1 2022
Q2Q % growth
-0.10
-25.00%
-0.08-0.02-22.55%
Q4 2021
Q2Q % growth
-0.11
-650.00%
-0.08-0.03-43.79%
Q3 2021
Q2Q % growth
-0.02
33.33%
-0.070.0571.99%
Q2 2021
Q2Q % growth
-0.01
85.71%
-0.070.0685.99%
Q1 2021
Q2Q % growth
-0.08
27.27%
-0.06-0.02-30.72%
Q4 2020
Q2Q % growth
0.02
115.38%
-0.060.08135.65%
Q3 2020
Q2Q % growth
-0.03
76.92%
-0.100.0769.04%
Q2 2020
Q2Q % growth
-0.07
30.00%
-0.100.0327.76%
Q4 2019
Q2Q % growth
-0.13 -0.10-0.03-34.16%
Q3 2019
Q2Q % growth
-0.13 -0.11-0.02-15.86%
Q2 2019
Q2Q % growth
-0.10 -0.110.016.63%
VTVT Yearly EPS VS EstimatesVTVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -50 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth

-100.00%
%
Q2 2023
Q2Q % growth

-100.00%
%
Q1 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth
10K 10K%
Q3 2022
Q2Q % growth

-100.00%
255K-255K-100.00%
Q2 2022
Q2Q % growth
10K 10K%
Q1 2022
Q2Q % growth
2M
102.02%
2M%
Q4 2021
Q2Q % growth
10K
-99.84%
1.02M-1.01M-99.02%
Q3 2021
Q2Q % growth
3M
29,900.00%
1.326M1.674M126.24%
Q2 2021
Q2Q % growth
10K 1.02M-1.01M-99.02%
Q1 2021
Q2Q % growth
990K
9,800.00%
816K174K21.32%
Q4 2020
Q2Q % growth
6.4M
63,900.00%
1.683M4.717M280.27%
Q3 2020
Q2Q % growth
10K 10K%
Q2 2020
Q2Q % growth

-100.00%
%
Q1 2020
Q2Q % growth
10K
-98.91%
10K%
Q4 2019
Q2Q % growth
10K 2.55M-2.54M-99.61%
Q3 2019
Q2Q % growth
10K 1.721M-1.711M-99.42%
Q2 2019
Q2Q % growth
1.83M 1.658M172K10.37%
VTVT Yearly Revenue VS EstimatesVTVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024 2028 2029 2030 20M 40M 60M 80M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 26.34% 0% 12.07%
RevenueN/A N/A N/A N/A